The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Fagan A, Fuld J, Soon E

Levetiracetam-induced eosinophilic pneumonia.

BMJ case reports 2017 Mar 08;2017; — 2017 Mar 08

Gómez-Zorrilla S, Ferraz AV, Pedrós C, Lemus M, Peña C

Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome.

The Annals of pharmacotherapy 2012 Jul-Aug;46;e20 — 2012 Jul-Aug — e20